GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the N-terminal domain of HIV-1 capsid in complex with inhibitor bi-1

Analyse Crystal structure of the N-terminal domain of HIV-1 capsid in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4J93
Type
protein
Length
146 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Gag protein
UniProt
Q79791
Ligands
0OE, 1JR
Pockets
1 · best druggability 0.32

Structure

x-ray diffraction · 1 distinct chain · 58% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGag proteinprotein14658% helix, 4% strandQ79791

Ligands and binding sites

  • 0OE · 4-{2-[5-(3-chlorophenyl)-1H-pyrazol-4-yl]-1-[3-(1H-imidazol-1-yl)propyl]-1H-benzimidazol-5-yl}benzoic acid · ligand · chains A
  • 1JR · (4S)-3-phenyl-4-(pyridin-3-yl)-4,5-dihydropyrrolo[3,4-c]pyrazol-6(2H)-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1570.320.76121JR

Compared structures

  • 4J93 · Crystal Structure of the N-Terminal Domain of HIV-1 Capsid in Complex With Inhibitor BI-1 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.